CASPOFUNGIN CIPLA caspofungin (as acetate) 70 mg powder for injection vial

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

caspofungin acetate, Quantity: 77.69 mg (Equivalent: caspofungin, Qty 70 mg)

Доступна с:

Cipla Australia Pty Ltd

Фармацевтическая форма:

Injection, powder for

состав:

Excipient Ingredients: sucrose; mannitol; glacial acetic acid; sodium hydroxide

Администрация маршрут:

Intravenous

Терапевтические показания :

CASPOFUNGIN CIPLA is indicated for: ? Empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? Treatment of: - Invasive Candidiasis, including candidaemia - Oesophageal Candidiasis - Invasive Aspergillosis in patients who are refractory to or intolerant of other therapies

Обзор продуктов:

Visual Identification: White to off white powder or cake; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Статус Авторизация:

Registered

Дата Авторизация:

2018-01-12